SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-008188
Filing Date
2014-02-06
Accepted
2014-02-06 20:38:28
Documents
2
Period of Report
2014-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3783
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4632
  Complete submission text file 0001209191-14-008188.txt   9991
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2140 S DUPONT HIGHWAY CAMDEN DE 19934
Business Address 2140 S DUPONT HIGHWAY CAMDEN DE 19934 818-274-1121
TFG USA, LLC (Reporting) CIK: 0001543423 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35443 | Film No.: 14581613